CO5590899A2 - Combinacion farmaceutica - Google Patents
Combinacion farmaceuticaInfo
- Publication number
- CO5590899A2 CO5590899A2 CO04052217A CO04052217A CO5590899A2 CO 5590899 A2 CO5590899 A2 CO 5590899A2 CO 04052217 A CO04052217 A CO 04052217A CO 04052217 A CO04052217 A CO 04052217A CO 5590899 A2 CO5590899 A2 CO 5590899A2
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- cycloalkyl
- alkenyl
- group
- groups
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Abstract
1.- Una combinación inhalada de (a) un inhibidor selectivo de PDE4 de fórmula: o una de sus sales o solvatos farmacéuticamente aceptables, en la que R1 es H, alquilo C1-C6, alcoxi C1-C6, alquenilo C2-C4, fenilo, -N(CH3)2, cicloalquilo C3-C6, (cicloalquil C3-C6) (alquilo C1-C3) o acilo C1-C6, pudiendo estar los grupos alquilo, fenilo o alquenilo sustituidos con hasta dos grupos -OH, alquilo C1-C3 o -CF3 o con hasta tres halógenos;cada uno de R2 y R3 se selecciona independientemente del grupo formado por H, alquilo C1-C14, (alcoxi C1-C7) (alquilo C1-C7), alquenilo C2-C14, cicloalquilo C3-C7, (cicloalquil C3-C7) (alquilo C1-C2), un grupo (heterocíclico C4-C7) (CH2)n saturado o insaturado en el que n es 0, 1 ó 2, que contiene como heteroátomo uno o más del grupo formado por oxígeno, azufre, sulfonilo, nitrógeno y NR4, siendo R4 H o alquilo C1-C4; o un grupo de Fórmula (II): en la que a es un número entero de 1 a 5; b y c son 0 ó 1; R5 es H, -OH, alquilo C1-C5, alquenilo C2-C5, alcoxi C1-C5, cicloalcoxi C3-C6, halógeno, -CF3, -CO2R6, -CONR6R7,-NR6R7, -NO2 o -SO2NR6R7, siendo cada uno de R6 y R7 independientemente H o alquilo C1-C4; Z es -O-, -S-, -SO2-, -CO- o -N(R8) -, siendo R8 H o alquilo C1-C4; e Y es alquileno C1-C5 o alquenileno C2-C6, opcionalmente sustituido con hasta dos grupos alquilo C1-C7 o cicloalquilo C3-C7;pudiendo estar cada uno de los grupos alquilo, alquenilo, cicloalquilo, alcoxialquilo o heterociclico sustituidos con 1 a 14, preferiblemente 1 a 5 grupos alquilo C1-C2, CF3 o halo; y cada uno de R9 y R10 se selecciona independientemente del grupo formado por H, alquilo C1-C6, alcoxi C1-C6, arilo C6-C10 y ariloxi C6-C10;y (b) un agonista del receptor ß2-adrenérgico.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0129395.0A GB0129395D0 (en) | 2001-12-07 | 2001-12-07 | Pharmaceutical combination |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5590899A2 true CO5590899A2 (es) | 2005-12-30 |
Family
ID=9927247
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO04052217A CO5590899A2 (es) | 2001-12-07 | 2004-06-04 | Combinacion farmaceutica |
Country Status (33)
Country | Link |
---|---|
US (2) | US20030119862A1 (es) |
EP (1) | EP1455783A1 (es) |
JP (1) | JP2005511657A (es) |
KR (1) | KR20050044699A (es) |
CN (1) | CN1599609A (es) |
AP (1) | AP2004003054A0 (es) |
AR (1) | AR037712A1 (es) |
AU (1) | AU2002353255A1 (es) |
BR (1) | BR0214776A (es) |
CA (1) | CA2468676A1 (es) |
CO (1) | CO5590899A2 (es) |
EA (1) | EA200400640A1 (es) |
EC (1) | ECSP045142A (es) |
GB (1) | GB0129395D0 (es) |
HN (1) | HN2002000356A (es) |
HR (1) | HRP20040515A2 (es) |
HU (1) | HUP0402546A3 (es) |
IL (1) | IL162098A0 (es) |
IS (1) | IS7277A (es) |
MA (1) | MA27152A1 (es) |
MX (1) | MXPA04004930A (es) |
NO (1) | NO20042870L (es) |
NZ (1) | NZ533030A (es) |
OA (1) | OA12736A (es) |
PA (1) | PA8560601A1 (es) |
PE (1) | PE20031066A1 (es) |
PL (1) | PL370770A1 (es) |
SV (1) | SV2004001430A (es) |
TN (1) | TNSN04102A1 (es) |
TW (1) | TWI242433B (es) |
UY (1) | UY27564A1 (es) |
WO (1) | WO2003047578A1 (es) |
ZA (1) | ZA200403905B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
TWI359675B (en) * | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
DE10360954B3 (de) * | 2003-12-23 | 2005-08-18 | Esparma Gmbh | Verwendung von Silibinin, dessen Salzen und/oder dessen Prodrugs zusammen mit α-Liponsäure zur Behandlung chronisch obstruktiver Lungenerkrankungen |
WO2012098495A1 (en) * | 2011-01-19 | 2012-07-26 | Glenmark Pharmaceuticals Sa | Pharmaceutical composition that includes revamilast and a beta-2 agonist |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0837860T3 (da) * | 1995-06-06 | 2002-05-27 | Pfizer | Tricykliske 5,6-dihydro-9H-pyrazolo[3,4-c]-1,2,4-triazolo-[4,3-alfa]pyridiner |
BR9913152A (pt) * | 1998-08-26 | 2001-05-15 | Smithkline Beecham Corp | Terapias para tratamento de doenças pulmonares |
KR100701904B1 (ko) * | 1999-08-21 | 2007-04-02 | 알타나 파마 아게 | Pde 억제제 및 베타 2 아드레날린수용체 작동제의상승적 조합 |
-
2001
- 2001-12-07 GB GBGB0129395.0A patent/GB0129395D0/en not_active Ceased
-
2002
- 2002-11-22 JP JP2003548833A patent/JP2005511657A/ja not_active Withdrawn
- 2002-11-22 MX MXPA04004930A patent/MXPA04004930A/es unknown
- 2002-11-22 AP APAP/P/2004/003054A patent/AP2004003054A0/en unknown
- 2002-11-22 IL IL16209802A patent/IL162098A0/xx unknown
- 2002-11-22 EP EP02788275A patent/EP1455783A1/en not_active Withdrawn
- 2002-11-22 EA EA200400640A patent/EA200400640A1/ru unknown
- 2002-11-22 PL PL02370770A patent/PL370770A1/xx not_active Application Discontinuation
- 2002-11-22 BR BR0214776-9A patent/BR0214776A/pt not_active IP Right Cessation
- 2002-11-22 WO PCT/IB2002/004922 patent/WO2003047578A1/en not_active Application Discontinuation
- 2002-11-22 AU AU2002353255A patent/AU2002353255A1/en not_active Abandoned
- 2002-11-22 HU HU0402546A patent/HUP0402546A3/hu unknown
- 2002-11-22 CN CNA028243935A patent/CN1599609A/zh active Pending
- 2002-11-22 NZ NZ533030A patent/NZ533030A/en not_active IP Right Cessation
- 2002-11-22 CA CA002468676A patent/CA2468676A1/en not_active Abandoned
- 2002-11-22 OA OA1200400162A patent/OA12736A/en unknown
- 2002-11-22 KR KR1020047008613A patent/KR20050044699A/ko active IP Right Grant
- 2002-12-03 US US10/308,962 patent/US20030119862A1/en not_active Abandoned
- 2002-12-05 PE PE2002001175A patent/PE20031066A1/es not_active Application Discontinuation
- 2002-12-05 HN HN2002000356A patent/HN2002000356A/es unknown
- 2002-12-05 AR ARP020104719A patent/AR037712A1/es unknown
- 2002-12-05 UY UY27564A patent/UY27564A1/es not_active Application Discontinuation
- 2002-12-06 TW TW091135479A patent/TWI242433B/zh not_active IP Right Cessation
- 2002-12-06 PA PA20028560601A patent/PA8560601A1/es unknown
- 2002-12-06 SV SV2002001430A patent/SV2004001430A/es not_active Application Discontinuation
-
2003
- 2003-12-16 US US10/736,996 patent/US20040167153A1/en not_active Abandoned
-
2004
- 2004-05-20 ZA ZA200403905A patent/ZA200403905B/en unknown
- 2004-05-21 IS IS7277A patent/IS7277A/is unknown
- 2004-06-02 MA MA27712A patent/MA27152A1/fr unknown
- 2004-06-04 TN TNP2004000102A patent/TNSN04102A1/fr unknown
- 2004-06-04 CO CO04052217A patent/CO5590899A2/es not_active Application Discontinuation
- 2004-06-07 HR HR20040515A patent/HRP20040515A2/hr not_active Application Discontinuation
- 2004-06-07 EC EC2004005142A patent/ECSP045142A/es unknown
- 2004-07-06 NO NO20042870A patent/NO20042870L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5640041A2 (es) | Un inhibidor de pde4 y un agente anticolinergico en combinacion para tratar enfermedades obstructivas de vias respiratorias | |
AR105103A1 (es) | Derivados hidroxiéster, un proceso para su preparación y composiciones farmacéuticas que los contienen | |
AR055592A1 (es) | Derivados de 2-amino-5-cicloalquil-hidantoina como moduladores y/o inhibidores de la beta-secretasa(bace) | |
AR082826A2 (es) | Inhibidores heterociclicos de mek, composiciones farmaceuticas que los contienen, usos, y metodos de preparacion de los mismos | |
AR095192A1 (es) | Quinolina y quinazolinamidas como modulares de canales de sodio | |
AR061739A1 (es) | Nuevos derivados naftalenicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
AR053340A1 (es) | Derivados de trifluormetilbenzamida y sus usos terapeuticos | |
AR058287A1 (es) | Derivados de isoquinolina y composicion farmaceutica | |
AR037489A1 (es) | Quinolinas sustituidas y proceso para su preparacion | |
CO5690579A2 (es) | Derivados de diarilcicloalquilo, metodo para su produccion y su uso como medicamentos | |
AR044561A1 (es) | Derivados de estatina | |
CO4900032A1 (es) | Nuevos derivados de benzamidina | |
AR070263A1 (es) | Derivados de oxazepinopirimidinona arilamido sustituidos, utiles en el tratamiento y/o prevencion de enfermedades neurodegenerativas y otras, medicamentos que los contienen y proceso de preparacion e intermediarios. | |
AR094852A1 (es) | Oestra-1,3,5(10),16-tetraeno-3-carboxamidas | |
AR066604A1 (es) | Derivados de arilamida pirimidona, medicamentos que los contienen y usos terapeuticos para prevenir y/o tratar enfermedades neurodegenerativas fundamentalmente. | |
AR045155A1 (es) | Derivados de 6-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos | |
AR066605A1 (es) | Derivados de heteroarilamida pirimidona | |
AR050153A1 (es) | Beta-agonistas, procedimiento para su preparacion y su uso como medicamentos | |
AR057464A1 (es) | Procedimiento para la preparacion de derivados de sulfonamida | |
AR047606A1 (es) | 4-oxobenzonitrilos como moduladores de receptores de androgenos,composiciones farmaceuticas que los contienen y usos | |
AR046793A1 (es) | Derivados de pirazol, antagonistas del receptor de la orexina | |
AR066603A1 (es) | Derivados de arilamida pirimidona | |
AR054747A1 (es) | Compuestos de indanil-piperazina un procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
CO4700460A1 (es) | 5,6-DIHIDRO-9H-PIRAZOL[3,4-c]-1,2,4-TRIAZOL[4,3-a] PIRIDINAS TRICICLICAS | |
AR042362A1 (es) | Derivados de 3h-quinazolin-4-ona, proceso de obtencion y composiciones farmaceuticas que los contienen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |